These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Non-destructive determination of the coating film thickness by X-ray powder diffractometry and correlation with the dissolution behavior of film-coated tablets. Yamada H, Terada K, Suryanarayanan R. J Pharm Biomed Anal; 2010 Mar 11; 51(4):952-7. PubMed ID: 19945243 [Abstract] [Full Text] [Related]
48. Precision and detection limit of quality test for amorphous drug in powder X-ray diffractometry. Kitahara S, Ishizuka T, Kikkoji T, Matsuda R, Hayashi Y. Int J Pharm; 2004 Sep 28; 283(1-2):63-9. PubMed ID: 15363502 [Abstract] [Full Text] [Related]
49. The development of a modified dissolution method suitable for investigating powder mixtures. Shaw LR, Irwin WJ, Grattan TJ, Conway BR. Drug Dev Ind Pharm; 2002 Oct 28; 28(9):1147-53. PubMed ID: 12455473 [Abstract] [Full Text] [Related]
57. Surface analysis of powder binary mixtures with ATR FTIR spectroscopy. Planinsek O, Planinsek D, Zega A, Breznik M, Srcic S. Int J Pharm; 2006 Aug 17; 319(1-2):13-9. PubMed ID: 16730933 [Abstract] [Full Text] [Related]
58. Development and validation of X-ray diffraction method for quantitative determination of crystallinity in warfarin sodium products. Siddiqui A, Rahman Z, Korang-Yeboah M, Khan MA. Int J Pharm; 2015 Sep 30; 493(1-2):1-6. PubMed ID: 26209072 [Abstract] [Full Text] [Related]
59. Crystal growth formation in melt extrudates. Bruce C, Fegely KA, Rajabi-Siahboomi AR, McGinity JW. Int J Pharm; 2007 Aug 16; 341(1-2):162-72. PubMed ID: 17524578 [Abstract] [Full Text] [Related]
60. Antisolvent crystallization of pharmaceutical excipients from aqueous solutions and the use of preferred orientation in phase identification by powder X-ray diffraction. Crisp JL, Dann SE, Blatchford CG. Eur J Pharm Sci; 2011 Apr 18; 42(5):568-77. PubMed ID: 21382490 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]